How a molecule deletes neural chatter might help treat Angelman syndrome

Researchers from the University of Tokyo reveal how the presynaptic Ube3a E3 ligase, a causal factor in Angelman syndrome, eliminates neural chatter. The study helps find a better drug target for the Angelman syndrome treatment.

Leave A Comment

Your email address will not be published. Required fields are marked *